Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
Recro Pharma reports 2019 executive compensation
By ExecPay News
Published: March 27, 2020
Recro Pharma reported fiscal year 2019 executive compensation information on March 27, 2020.
In 2019, four executives at Recro Pharma received on average a compensation package of $2.3M, a 60% increase compared to previous year.
Average pay of disclosed executives at Recro Pharma
Gerri Henwood, Chief Executive Officer, received $4.6M in total, which increased by 90% compared to 2018. 56% of Henwood's compensation, or $2.6M, was in stock awards. Henwood also received $360K in non-equity incentive plan, $1.1M in option awards, $554K in salary, as well as $38K in other compensation.
Michael Celano, Chief Operating Officer, received a compensation package of $1.7M, which increased by 43% compared to previous year. 37% of the compensation package, or $635K, was in option awards.
Ryan Lake, Chief Financial Officer, earned $1.5M in 2019, a 95% increase compared to previous year.
Ryan D. Lake, Chief Financial Officer, received $1.5M in 2019.
Related executives
You may also like
Source: SEC filing on March 27, 2020.